Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta

  1. Eric Engelbrecht
  2. Michel V Levesque
  3. Liqun He
  4. Michael Vanlandewijck
  5. Anja Nitzsche
  6. Hira Niazi
  7. Andrew Kuo
  8. Sasha A Singh
  9. Masanori Aikawa
  10. Kristina Holton
  11. Richard L Proia
  12. Mari Kono
  13. William T Pu
  14. Eric Camerer
  15. Christer Betsholtz
  16. Timothy Hla  Is a corresponding author
  1. Harvard Medical School, United States
  2. Uppsala University, Sweden
  3. Université de Paris, INSERM U970, Paris Cardiovascular Research Center, France
  4. Brigham and Women's Hospital, Harvard Medical School, United States
  5. Harvard Medical School Research Computing, United States
  6. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, United States
  7. Boston Children's Hospital, Harvard Medical School, United States

Abstract

Despite the medical importance of G protein-coupled receptors (GPCRs), in vivo cellular heterogeneity of GPCR signaling and downstream transcriptional responses are not understood. We report the comprehensive characterization of transcriptomes (bulk and single-cell) and chromatin domains regulated by sphingosine 1-phosphate receptor-1 (S1PR1) in adult mouse aortic endothelial cells. First, S1PR1 regulates NFkB and nuclear glucocorticoid receptor pathways to suppress inflammation-related mRNAs. Second, S1PR1 signaling in the heterogenous endothelial cell (EC) subtypes occurs at spatially-distinct areas of the aorta. For example, a transcriptomically distinct arterial EC population at vascular branch points (aEC1) exhibits ligand-independent S1PR1/β-arrestin coupling. In contrast, circulatory S1P-dependent S1PR1/β-arrestin coupling was observed in non-branch point aEC2 cells that exhibit an inflammatory gene expression signature. Moreover, S1P/S1PR1 signaling regulates the expression of lymphangiogenic and inflammation-related transcripts in an adventitial lymphatic EC (LEC) population in a ligand-dependent manner. These insights add resolution to existing concepts of GPCR signaling and S1P biology.

Data availability

Sequencing data and processed files have been deposited in GEO under the accession GSE139065.

The following data sets were generated

Article and author information

Author details

  1. Eric Engelbrecht

    Vascular Biology Program, Boston Children's Hospital and Department of Surgery Deapartment of Surgery, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  2. Michel V Levesque

    Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  3. Liqun He

    Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Competing interests
    No competing interests declared.
  4. Michael Vanlandewijck

    Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Competing interests
    No competing interests declared.
  5. Anja Nitzsche

    Université de Paris, INSERM U970, Paris Cardiovascular Research Center, Paris, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0567-6790
  6. Hira Niazi

    Université de Paris, INSERM U970, Paris Cardiovascular Research Center, Paris, France
    Competing interests
    No competing interests declared.
  7. Andrew Kuo

    Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  8. Sasha A Singh

    Center for Interdisciplinary Cardiovascular Sciences, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  9. Masanori Aikawa

    Center for Interdisciplinary Cardiovascular Sciences, Brigham and Women's Hospital, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9275-2079
  10. Kristina Holton

    Harvard Medical School Research Computing, Boston, United States
    Competing interests
    No competing interests declared.
  11. Richard L Proia

    Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0456-1270
  12. Mari Kono

    Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2447-4350
  13. William T Pu

    Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4551-8079
  14. Eric Camerer

    Université de Paris, INSERM U970, Paris Cardiovascular Research Center, Paris, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6271-7125
  15. Christer Betsholtz

    Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Competing interests
    No competing interests declared.
  16. Timothy Hla

    Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School, Boston, United States
    For correspondence
    timothy.hla@childrens.harvard.edu
    Competing interests
    Timothy Hla, received grant support from ONO Pharmaceuticals (2015-2018), has filed patent applications on ApoM, ApoM-Fc and HDL containing ApoM (US 62/545,629, PCT/US2018/000202, US 62/744,903, PCT/US2019/055831, US16/326,089, CA3034243, CN201780056922.6, JP 2019-530362, EPO 17851271.1), and has consulted for the following commercial entities: Astellas, Steptoe and Johnson, Gerson Lehrman Group Council, Janssen Research & Development, LLC, and Sun Pharma advanced research group (SPARC).
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8355-4065

Funding

National Heart, Lung, and Blood Institute (R35 HL135821)

  • Timothy Hla

Fondation Leducq (SphingoNet Transatlantic Network Grant)

  • Richard L Proia
  • Eric Camerer
  • Christer Betsholtz
  • Timothy Hla

National Institute of Diabetes and Digestive and Kidney Diseases (Intramural program support)

  • Richard L Proia

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#16-10-3297) of the Boston Children's Hospital. All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 4,273
    views
  • 501
    downloads
  • 38
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Eric Engelbrecht
  2. Michel V Levesque
  3. Liqun He
  4. Michael Vanlandewijck
  5. Anja Nitzsche
  6. Hira Niazi
  7. Andrew Kuo
  8. Sasha A Singh
  9. Masanori Aikawa
  10. Kristina Holton
  11. Richard L Proia
  12. Mari Kono
  13. William T Pu
  14. Eric Camerer
  15. Christer Betsholtz
  16. Timothy Hla
(2020)
Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta
eLife 9:e52690.
https://doi.org/10.7554/eLife.52690

Share this article

https://doi.org/10.7554/eLife.52690

Further reading

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    Omid Gholamalamdari, Tom van Schaik ... Andrew S Belmont
    Research Article

    Models of nuclear genome organization often propose a binary division into active versus inactive compartments yet typically overlook nuclear bodies. Here, we integrated analysis of sequencing and image-based data to compare genome organization in four human cell types relative to three different nuclear locales: the nuclear lamina, nuclear speckles, and nucleoli. Although gene expression correlates mostly with nuclear speckle proximity, DNA replication timing correlates with proximity to multiple nuclear locales. Speckle attachment regions emerge as DNA replication initiation zones whose replication timing and gene composition vary with their attachment frequency. Most facultative LADs retain a partially repressed state as iLADs, despite their positioning in the nuclear interior. Knock out of two lamina proteins, Lamin A and LBR, causes a shift of H3K9me3-enriched LADs from lamina to nucleolus, and a reciprocal relocation of H3K27me3-enriched partially repressed iLADs from nucleolus to lamina. Thus, these partially repressed iLADs appear to compete with LADs for nuclear lamina attachment with consequences for replication timing. The nuclear organization in adherent cells is polarized with nuclear bodies and genomic regions segregating both radially and relative to the equatorial plane. Together, our results underscore the importance of considering genome organization relative to nuclear locales for a more complete understanding of the spatial and functional organization of the human genome.

    1. Chromosomes and Gene Expression
    Ashwin Govindan, Nicholas K Conrad
    Research Article

    O-GlcNAcylation is the reversible post-translational addition of β-N-acetylglucosamine to serine and threonine residues of nuclear and cytoplasmic proteins. It plays an important role in several cellular processes through the modification of thousands of protein substrates. O-GlcNAcylation in humans is mediated by a single essential enzyme, O-GlcNAc transferase (OGT). OGT, together with the sole O-GlcNAcase OGA, form an intricate feedback loop to maintain O-GlcNAc homeostasis in response to changes in cellular O-GlcNAc using a dynamic mechanism involving nuclear retention of its fourth intron. However, the molecular mechanism of this dynamic regulation remains unclear. Using an O-GlcNAc responsive GFP reporter cell line, we identify SFSWAP, a poorly characterized splicing factor, as a trans-acting factor regulating OGT intron detention. We show that SFSWAP is a global regulator of retained intron splicing and exon skipping that primarily acts as a negative regulator of splicing. In contrast, knockdown of SFSWAP leads to reduced inclusion of a ‘decoy exon’ present in the OGT retained intron which may mediate its role in OGT intron detention. Global analysis of decoy exon inclusion in SFSWAP and UPF1 double knockdown cells indicate altered patterns of decoy exon usage. Together, these data indicate a role for SFSWAP as a global negative regulator of pre-mRNA splicing and positive regulator of intron retention.